SX-HIV1

N/A

Report date: 2025/06/11 10:49:42

NME

Base Information

Drug NameSX-HIV1

Drug Alias NameRVI-L08SX-HIV1

ClassificationSmall molecules > Peptidomimetic

Mechanisms of ActionHIV integrase inhibitors

TargetsHIV integrase

Therapy Area/IndicationsRetroviridae Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSerometrix LLC

China Registration ClassN/A

Develop Information

Active CompaniesSerometrix LLC

Inactive CompaniesN/A

Active IndicationsRetroviridae Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A